(DGICA) Donegal - Overview
Stock: Commercial, Personal, Property, Casualty, Automobile, Workers
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.16% |
| Yield on Cost 5y | 6.38% |
| Yield CAGR 5y | 3.39% |
| Payout Consistency | 100.0% |
| Payout Ratio | 43.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.0% |
| Relative Tail Risk | -8.92% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.98 |
| Alpha | 24.13 |
| Character TTM | |
|---|---|
| Beta | 0.258 |
| Beta Downside | 0.214 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.84% |
| CAGR/Max DD | 0.69 |
Description: DGICA Donegal December 25, 2025
Donegal Group Inc. (NASDAQ:DGICA) is a U.S.-based insurance holding company that underwrites both commercial and personal property-and-casualty (P&C) policies. It operates through three segments – an Investment Function that manages the company’s investment portfolio, Commercial Lines that cover business auto, general liability and workers’ compensation, and Personal Lines that insure private passenger vehicles, homeowners and renters. Distribution is handled primarily through independent agents across the Mid-Atlantic, Midwest, Southern and Southwestern states, and the firm is a subsidiary of Donegal Mutual Insurance Company.
Key operational metrics from the most recent 2023 filing show a combined ratio of roughly 93%, indicating underwriting profitability, and net written premiums of about $560 million, up 4% year-over-year. Investment income contributed roughly $45 million, reflecting the firm’s exposure to higher-yielding fixed-income assets in a rising-rate environment. The P&C sector is currently driven by inflation-linked cost pressures on auto repairs and workers’ compensation claims, as well as heightened exposure to severe weather events that elevate catastrophe loss reserves.
For a deeper quantitative look, the ValueRay platform offers granular financial metrics and peer comparisons that can help you assess DGICA’s valuation relative to its peers.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 86.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.23 > 1.0 |
| NWC/Revenue: -4791 % < 20% (prev -47.50%; Δ -4743 % < -1%) |
| CFO/TA 0.04 > 3% & CFO 88.4m > Net Income 86.2m |
| Net Debt (-3.57m) to EBITDA (111.2m): -0.03 < 3 |
| Current Ratio: 0.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.1m) vs 12m ago -6.06% < -2% |
| Gross Margin: 26.85% > 18% (prev 0.40%; Δ 2644 % > 0.5%) |
| Asset Turnover: 47.64% > 50% (prev 56.71%; Δ -9.06% > 0%) |
| Interest Coverage Ratio: 84.09 > 6 (EBITDA TTM 111.2m / Interest Expense TTM 1.28m) |
Altman Z'' -15.00
| A: -19.55 (Total Current Assets 38.6m - Total Current Liabilities 47.38b) / Total Assets 2.42b |
| B: 0.12 (Retained Earnings 293.8m / Total Assets 2.42b) |
| C: 0.05 (EBIT TTM 107.6m / Avg Total Assets 2.07b) |
| D: 0.16 (Book Value of Equity 282.1m / Total Liabilities 1.79b) |
| Altman-Z'' Score: -127.3 = D |
Beneish M -2.15
| DSRI: 1.39 (Receivables 609.7m/434.1m, Revenue 988.2m/979.1m) |
| GMI: 1.51 (GM 26.85% / 40.44%) |
| AQI: 1.14 (AQ_t 0.98 / AQ_t-1 0.86) |
| SGI: 1.01 (Revenue 988.2m / 979.1m) |
| TATA: -0.00 (NI 86.2m - CFO 88.4m) / TA 2.42b) |
| Beneish M-Score: -2.15 (Cap -4..+1) = BB |
What is the price of DGICA shares?
Over the past week, the price has changed by +1.19%, over one month by -5.13%, over three months by -1.47% and over the past year by +31.21%.
Is DGICA a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DGICA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21 | 10.6% |
| Analysts Target Price | 21 | 10.6% |
| ValueRay Target Price | 22 | 15.7% |
DGICA Fundamental Data Overview February 05, 2026
P/E Forward = 16.0
P/S = 0.6974
P/B = 1.0979
P/EG = 3.06
Revenue TTM = 988.2m USD
EBIT TTM = 107.6m USD
EBITDA TTM = 111.2m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 35.0m USD (from shortTermDebt, last quarter)
Debt = 35.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.57m USD (from netDebt column, last quarter)
Enterprise Value = 211.5m USD (688.9m + Debt 35.0m - CCE 512.4m)
Interest Coverage Ratio = 84.09 (Ebit TTM 107.6m / Interest Expense TTM 1.28m)
EV/FCF = 2.39x (Enterprise Value 211.5m / FCF TTM 88.4m)
FCF Yield = 41.82% (FCF TTM 88.4m / Enterprise Value 211.5m)
FCF Margin = 8.95% (FCF TTM 88.4m / Revenue TTM 988.2m)
Net Margin = 8.72% (Net Income TTM 86.2m / Revenue TTM 988.2m)
Gross Margin = 26.85% ((Revenue TTM 988.2m - Cost of Revenue TTM 722.9m) / Revenue TTM)
Gross Margin QoQ = 26.83% (prev 22.95%)
Tobins Q-Ratio = 0.09 (Enterprise Value 211.5m / Total Assets 2.42b)
Interest Expense / Debt = 0.97% (Interest Expense 340.4k / Debt 35.0m)
Taxrate = 19.84% (4.97m / 25.0m)
NOPAT = 86.2m (EBIT 107.6m * (1 - 19.84%))
Current Ratio = 0.00 (Total Current Assets 38.6m / Total Current Liabilities 47.38b)
Debt / Equity = 0.06 (Debt 35.0m / totalStockholderEquity, last quarter 627.4m)
Debt / EBITDA = -0.03 (Net Debt -3.57m / EBITDA 111.2m)
Debt / FCF = -0.04 (Net Debt -3.57m / FCF TTM 88.4m)
Total Stockholder Equity = 590.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.15% (Net Income 86.2m / Total Assets 2.42b)
RoE = 14.58% (Net Income TTM 86.2m / Total Stockholder Equity 590.9m)
RoCE = 18.21% (EBIT 107.6m / Capital Employed (Equity 590.9m + L.T.Debt 0.0))
RoIC = 13.78% (NOPAT 86.2m / Invested Capital 625.9m)
WACC = 6.58% (E(688.9m)/V(723.9m) * Re(6.87%) + D(35.0m)/V(723.9m) * Rd(0.97%) * (1-Tc(0.20)))
Discount Rate = 6.87% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.41%
[DCF Debug] Terminal Value 82.60% ; FCFF base≈69.8m ; Y1≈64.4m ; Y5≈58.1m
Fair Price DCF = 46.25 (EV 1.43b - Net Debt -3.57m = Equity 1.44b / Shares 31.1m; r=6.58% [WACC]; 5y FCF grow -9.67% → 2.90% )
EPS Correlation: 48.85 | EPS CAGR: -21.75% | SUE: -1.72 | # QB: 0
Revenue Correlation: 93.13 | Revenue CAGR: 4.27% | SUE: 0.59 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=+0.190 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=2.10 | Chg30d=+0.125 | Revisions Net=+0 | Growth EPS=-2.3% | Growth Revenue=-1.0%